MiMedx Group Inc.

7.93
-0.04 (-0.50%)
At close: Mar 21, 2025, 3:59 PM
8.08
1.87%
After-hours: Mar 21, 2025, 05:36 PM EDT
-0.50%
Bid 7.74
Market Cap 1.17B
Revenue (ttm) 349.73M
Net Income (ttm) 42.52M
EPS (ttm) 0.28
PE Ratio (ttm) 28.32
Forward PE 29.23
Analyst Buy
Ask 8.23
Volume 430,391
Avg. Volume (20D) 572,474
Open 7.92
Previous Close 7.97
Day's Range 7.88 - 8.00
52-Week Range 5.47 - 10.14
Beta 1.97

About MDXG

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its produc...

Industry Biotechnology
Sector Healthcare
IPO Date Feb 12, 2008
Employees 837
Stock Exchange NASDAQ
Ticker Symbol MDXG
Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for MDXG stock is "Buy." The 12-month stock price forecast is $12, which is an increase of 51.32% from the latest price.

Stock Forecasts

Next Earnings Release

MiMedx Group Inc. is scheduled to release its earnings on Apr 29, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+23.56%
MiMedx Group shares are trading higher after the c... Unlock content with Pro Subscription
4 months ago
+20.39%
MiMedx Group shares are trading higher after the company reported better-than-expected Q3 financial results.